24 Mar FDA Temporarily Suspends Enforcement of a Portion of Federal VCPR Requirements During COVID-19 Outbreak
On March 24, 2020, FDA has issued guidance, for immediate implementation, that temporarily suspends the enforcement of certain aspects of the federal veterinarian-client-patient-relationship (VCPR) requirements. Those federal requirements apply to extralabel drug use, the issuing of veterinary feed directives and the creation and use of certain veterinary biologics. The guidance acknowledges individual state VCPR requirements that may continue to exist, acknowledges current federal VCPR requirements related to in-person examinations or premises visits, and indicates suspension of requirements outlined in guidance are temporary measures during the COVID-19 outbreak.
PA Specific Guidelines:
Health care professionals licensed under any of the Department of State’s Bureau of Professional and Occupational Affairs (BPOA) licensing boards can provide services to patients via telemedicine during the coronavirus emergency. Currently, no Pennsylvania law prohibits the practice of telemedicine. Additionally, the department is working with the governor’s office, the Department of Health and Department of Human Services to identify regulations and requirements that can be suspended to give medical providers and facilities the flexibility they need to respond to the crisis. Click here for more information.